Home › Gaucher Disease › North Carolina
Gaucher Disease clinical trials in North Carolina
4 studies for Gaucher Disease are looking for participants at sites in North Carolina.
Cities in North Carolina
A Gaucher Disease Gene Therapy Trial With FLT201
- Duke University Medical Center, Durham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07223944A Long-term Follow-up Study of Gaucher Disease
- Duke University Medical Center, Durham
RecruitingObservational study
All ages · All sexes · Updated Sep 3, 2026 · NCT03190837International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
- Carolinas Medical Center Hospital- Site Number : 840065, Charlotte
- Duke University Medical Center Genetics Dept- Site Number : 840037, Durham
RecruitingObservational study
All ages · All sexes · Updated Apr 14, 2026 · NCT00358943Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
RecruitingPhase 1
18 Months · All sexes · Updated Mar 27, 2026 · NCT03721068From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.